Diabetes, glucose control, glucose lowering medications, and cancer risk: A 10-year population-based historical cohort
<p>Abstract</p> <p>Background</p> <p>Both diabetes and glucose-lowering medications have been associated with an increased risk of cancer incidence. This study will compare cancer incidence rates in individuals with and without diabetes; and will investigate, in individ...
Main Authors: | Dankner Rachel, Balicer Ran, Boffetta Paolo, Boker Lital, Wallenstein Sylvan, Freedman Laurence, Goldfracht Margalit, Roth Jesse, Tamler Ronald, LeRoith Derek |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/364 |
Similar Items
-
The triglyceride-glucose index predicts ischemic heart disease risk in Koreans: a prospective study using National Health Insurance Service data
by: Byoungjin Park, et al.
Published: (2020-12-01) -
Apport d'une étude de cohorte pour mesurer l'incidence des tumeurs malignes rares : application concernant les sarcomes en région Rhône-Alpes
by: Ducimetière, Françoise
Published: (2009) -
A Significant Decrease in the Incidence of Shigellosis in Israel during COVID-19 Pandemic
by: Ravit Bassal, et al.
Published: (2021-03-01) -
Trends of Thyroid Cancer in Israel: 1980–2012
by: Lital Keinan-Boker, et al.
Published: (2016-01-01) -
Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms.
by: Xiaosong Li, et al.
Published: (2011-02-01)